NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes
      QxMD      Google Scholar   
Citation:
Menopause vol 22 (6) 627-632
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
4
Parents:
2099  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, CA33601, U10 CA037417, N01 CA035431, CA-37404, CA-35090, UG1 CA189825, U10 CA031946, U10 CA033601, CA-35195, U10 CA037404, U10 CA180821, UG1 CA189805, N01 CA035119, U10 CA035448, U10 CA063848, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, UG1 CA189823, U10 CA035113, P30 CA015083, CA-63848, U10 CA035415, U10 CA063849, U10 CA180882, CA-35415, U10 CA035431, U10 CA035119, UG1 CA189808, CA-37417, CA-35448, CA-35101, U10 CA025224, U10 CA035090, CA31946, CA-35267, CA-63849, U10 CA035103  
Corr. Author:
 
Authors:
                           
Networks:
 
Study
NCCTG-N10C2
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
magnesium, hot flashes, breast cancer survivorship